Five months after giving up on its lead drug Betalutin for follicular lymphoma, Nordic Nanovector has charted a course forward via a merger with fellow Norwegian biotech APIM Therapeutics. The merger ...
Son of Slain Ayatollah Is Expected to Continue Hard-Line Theocratic Rule U.S. continues striking a wide array of targets in Iran. The U.S. issued a warning to civilians in Iran. Whether they receive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results